Evolent Health, Inc (EVH) News
Filter EVH News Items
EVH News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
EVH News Highlights
- For EVH, its 30 day story count is now at 6.
- Over the past 6 days, the trend for EVH's stories per day has been choppy and unclear. It has oscillated between 1 and 2.
- The most mentioned tickers in articles about EVH are ACT.
Latest EVH News From Around the Web
Below are the latest news stories about EVOLENT HEALTH INC that investors may wish to consider to help them evaluate EVH as an investment opportunity.
Investors Will Want Evolent Health's (NYSE:EVH) Growth In ROCE To PersistThere are a few key trends to look for if we want to identify the next multi-bagger. Typically, we'll want to notice a... |
How Much Upside is Left in Evolent Health (EVH)? Wall Street Analysts Think 59.66%The consensus price target hints at a 59.7% upside potential for Evolent Health (EVH). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term. |
Insider Sell: CEO Seth Blackley Sells 141,000 Shares of Evolent Health Inc (EVH)In a notable insider transaction, CEO Seth Blackley has sold 141,000 shares of Evolent Health Inc (NYSE:EVH) on December 5, 2023. |
Evolent Health Looks to Start an Advance, But When?Evolent Health, Inc. was rated a new market outperform (buy) at JMP Securities with a $37 price target. Evolent provides "an integrated administrative and clinical platform for health plan administration and population health management". In this daily bar chart of EVH, below, I can see that prices have made a choppy decline since April. |
Evolent Health, Inc. Announces Pricing of $350.0 Million of Convertible Senior Notes Due 2029 to Pay Down Senior Term LoanEvolent Health, Inc. (NYSE: EVH), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable ("Evolent"), today announced the pricing of $350.0 million aggregate principal amount of 3.50% convertible senior notes due 2029. The notes are being offered only to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the |
Evolent Health, Inc. Announces Proposed Offering of $350.0 Million of Convertible Senior Notes Due 2029 to Pay Down Senior Term LoanEvolent Health, Inc. (NYSE: EVH), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable ("Evolent"), today announced that it intends to offer $350.0 million aggregate principal amount of convertible senior notes due 2029, subject to market and other conditions. Evolent also expects to grant the initial purchasers in the proposed offering an option to purchase up to an additional $52.5 mil |
Best Momentum Stocks to Buy for November 20thEVH, ACGL and AREC made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on November 20, 2023. |
Wall Street Analysts See a 56.84% Upside in Evolent Health (EVH): Can the Stock Really Move This High?The average of price targets set by Wall Street analysts indicates a potential upside of 56.8% in Evolent Health (EVH). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock. |
Evolent Health, Inc. (NYSE:EVH) Q3 2023 Earnings Call TranscriptEvolent Health, Inc. (NYSE:EVH) Q3 2023 Earnings Call Transcript November 4, 2023 Operator: Welcome to the Evolent Earnings Conference Call for the quarter ended September 30th, 2023. As a reminder, this conference call is being recorded. Your hosts for the call today from Evolent are Seth Blackley, chief executive officer; and John Johnson, chief financial […] |
Is There An Opportunity With Evolent Health, Inc.'s (NYSE:EVH) 49% Undervaluation?Key Insights Using the 2 Stage Free Cash Flow to Equity, Evolent Health fair value estimate is US$53.12 Current share... |